2021 HPTN Annual Meeting

2021 Annual Meeting banner
May 17, 19, 21, 2021

The 2021 HPTN Annual Meeting took place virtually May 17, 19, and 21. The meeting featured a variety of HIV and COVID-19 prevention research presentations and discussions, as well as interactive Q&A sessions. 

Title Speaker
SURVIVING SARS-COV2: LESSONS FROM 40+ YEARS OF HIV RESEARCH Dr. Myron S. Cohen
HPTN: SCIENTIFIC AIMS FOR 2021 AND BEYOND Dr. Wafaa M. El-Sadr
MULTIPURPOSE PREVENTION TECHNOLOGIES FOR HIV PREVENTION: THE VISION, THE APPROACHES, AND THE CHALLENGES Dr. Julie Pulerwitz and Dr. Lisa Haddad

CABOTEGRAVIR ROUNDTABLE DISCUSSION: PAST, PRESENT AND FUTURE 

Dr. Raphael J. Landovitz (HPTN 083)

Dr. Sinead Delany-Moretlwe (HPTN 084)

Dr. Sybil Hosek (HPTN 083-01/HPTN 084-01)

HPTN 083: HIV VIROLOGY AND DRUG RESISTANCE  IN THE SETTING OF CAB LA PREP Dr. Susan Eshleman
HIV PREVENTION AND THE VAGINAL MICROBIOME Dr. Betsy Herold
SOURCE AND RECIPIENT CHARACTERISTICS OF HIV TRANSMISSION PAIRS IDENTIFIED IN THE HPTN 071 PHYLOGENETICS PROJECT Dr. Matthew Hall

 

May 19, 2021

Title Speaker
NIAID PRIORITIES IN HIV/AIDS RESEARCH  Dr. Anthony S. Fauci
PREP SCALE-UP, SUCCESS AND CHALLENGES Dr. Rachel Baggaley
HPTN 094: A PERSON-CENTERED, PUBLIC HEALTH APPROACH TO ADDRESS HIV AND THE U.S. OPIOID CRISES  Dr. Steven Shoptaw
HPTN 096: INTEGRATING MULTI-LEVEL STRATEGIES TO REDUCE HIV TRANSMISSION AMONG BLACK MSM IN THE SOUTHERN U.S. Dr. LaRon Nelson
CLASSES OF SEXUAL IDENTITY, HOMOPHOBIA, AND SEXUAL RISK AMONG BLACK SEXUAL MINORITIES IN HPTN 061 Dr. Rodman Turpin
AN EXAMINATION OF PERCEIVED AUTONOMY SUPPORT, CARE COORDINATION QUALITY, AND PREP DISCONTINUATION AMONG BLACK MSM IN THREE U.S. CITIES: HPTN 073  Dr. Raquel Ramos
HIGHER COLORECTAL TISSUE INFECTIVITY IN HIV SERONEGATIVE CISGENDER WOMEN COMPARED TO MSM BOTH WITH & WITHOUT ORAL ANTIRETROVIRAL (ARV) PREP REGIMENS IN HPTN 069 STUDY Dr. Rogers Sekabira
FACTORS ASSOCIATED WITH DAILY AND NON-DAILY SEX-RELATED PREP ADHERENCE AMONG WOMEN IN CAPE TOWN IN THE HPTN 067/ADAPT STUDY Elzette Rousseau
SEXUAL RISK PROFILES AMONG BLACK SEXUAL MINORITY MEN: IMPLICATIONS FOR TARGETED PREP MESSAGING: HPTN 073 Dr. Derek Dangerfield II
IDENTIFYING PREDICTIVE FACTORS FOR CONDOM USE IN MSM AND TGW IN SUB-SAHARAN AFRICA: RESULTS FROM HPTN 075 Dr. Anita Marais

May 21, 2021

Title Speaker
HPTN 091: LESSONS LEARNED INCORPORATING LIVED EXPERIENCES TO STRENGTHEN RESEARCH DESIGN  Nora Howell and Mia Ryan Porter
USING CROSS-SECTIONAL RECENCY ASSAYS TO ASSESS PREVENTION EFFICACY: FUTURE TRIAL DESIGN AND SAMPLE SIZE CONSIDERATIONS Dr. Fei Gao
WHAT IS A WIN? DEFINING EFFICACY GOALS IN A TRIAL DESIGNED WITH A PLACEBO COUNTERFACTUAL  Dr. Jim Hughes
ESTIMATING THE EFFICACY OF LONG-ACTING PREP WITH A MODEL-BASED COUNTERFACTUAL PLACEBO Dr. Mia Moore
ESTIMATING THE IMPACT OF PREP REGIMENS CONTAINING LONG-ACTING INJECTABLE CABOTEGRAVIR OR DAILY ORAL TDF/FTC AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES: MATHEMATICAL MODELLING FOR HPTN 083  Dr. Kate Mitchell
NETWORK AWARDS Dr. Quarraisha Abdool Karim